News & Updates
  • Home
  • About Us
  • Contact
  • Home 1
  • News & Updates

    Patented New ISO Name Approved – December 2025: Triflupyroxazin, A New N-phenylimide Herbicide From Liaoning Cynda Chemical Co., Ltd.

    Patented New ISO Name Approved – December 2025: Amfenamacril, A New Aminocyanoacrylate Fungicide From Jiangsu Pesticide Research Institute Co., Ltd.

    Delhi HC refuses FMC’s plea to stop Natco’s Cyantraniliprole commercialization

    Sartorius Completes Acquisition of Novasep’s Chromatography Division

    adminFebruary 10, 202201.9k views

    Summary : The life science group Sartorius announced today that, through its subgroup Sartorius Stedim Biotech, it closed the acquisition of the…

    Read more

    Sanofi completes acquisition of Amunix

    adminFebruary 10, 202201.7k views

    Summary : Sanofi announced the completion of its acquisition of Amunix Pharmaceuticals, Inc, adding a promising pipeline of T-cell engagers and cytokine…

    Read more

    Amgen 2021 Revenue Propped up by COVID-19 Manufacturing Collab

    adminFebruary 9, 202201.7k views

    Summary : Amgen has posted a 3% rise in total 2021 fourth-quarter revenues to $6.8 billion and a 2% increase in total revenue for the year…

    Read more

    After Watershed Year, Pfizer Expects Revenue to Top $98B in ’22

    adminFebruary 9, 202201.8k views

    Summary : Pfizer Chief Executive Officer Albert Bourla called 2021 a watershed year for the company. It posted $81.3 billion in revenue…

    Read more

    Alzheon Alzheimer’s Asset Poised for Phase III with High Hopes

    adminFebruary 9, 202201.6k views

    Synopsis : Alzheon today posted positive results from its Phase II biomarker trial on ALZ-801 (valiltramiprosate) in patients diagnosed with neurodegenerative disorders…

    Read more

    Samsung Biologics receives 2022 CMO Leadership Award in all six categories

    adminFebruary 9, 202201.6k views

    Summary : Samsung Biologics, the world’s leading contract development and manufacturing organization (CDMO), announced that it has been selected as a winner…

    Read more

    Suppressing the spread of tumors

    adminFebruary 9, 202201.6k views

    Why some patients develop metastases and others do not is largely unclear. Researchers around ISTA professor Daria Siekhaus are now contributing to…

    Read more

    With personalized medicine, a shelved cancer drug could get another shot

    adminFebruary 9, 202201.6k views

    Summary – A study by Virginia Commonwealth University Massey Cancer Center researchers published in today’s print edition of Molecular Cancer Therapeutics shows…

    Read more

    Avalo Therapeutics to Present at the 2022 BIO CEO and Investor Conference

    adminFebruary 8, 202201.7k views

    Avalo Therapeutics, Inc. (Nasdaq: AVTX), a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant…

    Read more

    Biogen and Xbrane Announce Commercialization and License Agreement for Proposed Biosimilar Referencing CIMZIA® (Certolizumab pegol) with the Potential to Treat Rheumatoid Arthritis

    adminFebruary 8, 202201.6k views

    Summary : Biogen Inc. (Nasdaq: BIIB) and Xbrane Biopharma AB (STO: XBRANE) today announced that they have entered into a commercialization and…

    Read more

    Posts navigation

    1 … 47 … 105
    View Desktop Version

    Powered by PenciDesign

    Back To Top